Therapeutic drug monitoring on the use of transplacental digoxin in fetal tachyarrhythmia: a case report

Fetal tachycardia (FT) is a rare disorder and is associated with significant mortality of fetus. Digoxin is one of the antiarrhythmic agents used to treat FT via transplacental therapy. In this report, we describe a therapeutic drug monitoring (TDM) case of digoxin during the treatment of FT. A 40-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Sae Im, Won, Heejae, Song, Ildae, Oh, Jaeseong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253450/
https://www.ncbi.nlm.nih.gov/pubmed/35800665
http://dx.doi.org/10.12793/tcp.2022.30.e11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253450/
https://www.ncbi.nlm.nih.gov/pubmed/35800665
http://dx.doi.org/10.12793/tcp.2022.30.e11

Ejemplares similares